Alpine Associates Management Inc. grew its position in shares of Aetna (NYSE:AET) by 72.1% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 1,525,600 shares of the company’s stock after purchasing an additional 639,000 shares during the quarter. Aetna accounts for 8.5% of Alpine Associates Management Inc.’s portfolio, making the stock its largest position. Alpine Associates Management Inc. owned about 0.47% of Aetna worth $257,827,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in AET. TIAA FSB boosted its position in shares of Aetna by 12.0% in the fourth quarter. TIAA FSB now owns 12,308 shares of the company’s stock worth $2,220,000 after buying an additional 1,322 shares during the period. IFG Advisory LLC acquired a new stake in Aetna during the fourth quarter valued at $382,000. Bessemer Group Inc. increased its stake in shares of Aetna by 19.8% in the fourth quarter. Bessemer Group Inc. now owns 13,363 shares of the company’s stock worth $2,410,000 after purchasing an additional 2,205 shares during the period. SignalPoint Asset Management LLC bought a new position in shares of Aetna in the fourth quarter worth about $216,000. Finally, Dupont Capital Management Corp increased its stake in shares of Aetna by 1,457.2% in the fourth quarter. Dupont Capital Management Corp now owns 24,838 shares of the company’s stock worth $4,481,000 after purchasing an additional 23,243 shares during the period. 84.99% of the stock is owned by institutional investors and hedge funds.
A number of equities research analysts recently weighed in on AET shares. Credit Suisse Group decreased their target price on Aetna from $208.00 to $194.00 and set a “neutral” rating on the stock in a research report on Monday, May 14th. Zacks Investment Research raised Aetna from a “sell” rating to a “hold” rating in a report on Thursday, May 3rd. Cantor Fitzgerald raised Aetna from a “neutral” rating to an “overweight” rating in a report on Tuesday, May 1st. Finally, ValuEngine downgraded Aetna from a “buy” rating to a “hold” rating in a report on Friday, June 1st. Nine investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Aetna currently has a consensus rating of “Hold” and an average target price of $196.36.
Aetna (NYSE:AET) last posted its quarterly earnings data on Tuesday, May 1st. The company reported $3.19 EPS for the quarter, topping the Zacks’ consensus estimate of $2.97 by $0.22. The company had revenue of $15.34 billion during the quarter, compared to the consensus estimate of $15.32 billion. Aetna had a net margin of 5.76% and a return on equity of 21.42%. The company’s quarterly revenue was up 1.1% on a year-over-year basis. During the same period in the prior year, the business posted $2.71 EPS. equities research analysts forecast that Aetna will post 11.06 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 1st. Shareholders of record on Wednesday, July 25th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, July 24th. This represents a $2.00 annualized dividend and a yield of 1.06%. Aetna’s dividend payout ratio is currently 20.28%.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.